The company was established in March 2021, with asymmetric hydrogenation technology as its core, focusing on providing research and development, customized production, and technology transfer services for raw materials and intermediates of new drugs and high-end generic drugs. The company has a research and development center and a KG level pilot plant in Ganzhou, as well as cooperative factories and GMP production bases in Chongqing and Liaoning. It can provide process production services and products for intermediates and raw materials in various stages of drug preclinical, clinical research, and commercialization.
corporate culture
Services
Having a comprehensive product design, testing, and technical service system
Pursuing Quality
The product has passed safety certification such as CCC, CE, FCC, EMC, etc
scientific management
Management has passed the ISO9001 quality management system and ISO14001 environmental management system
Corporate Honors
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
AAA诚信经营
corporate image
The company has a research and development site of over 4600 square meters, and has built multiple drug synthesis laboratories and several kilogram level laboratories in accordance with international standards. At the same time, it also has a high standard analysis and testing center equipped with advanced quality control instruments such as liquid chromatography-mass spectrometry, gas chromatography, and liquid chromatography.
